Thyronines as a New Chemotype of Transcriptional CDK Inhibitors: An HTS-Driven Drug Repurposing Study

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24414391
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Thyronines as a New Chemotype of Transcriptional CDK Inhibitors: An HTS-Driven Drug Repurposing Study

Sandip Bibishan Bharate
Zenodo (CERN European Organization for Nuclear Research)
Computational Drug Discovery Methods
article

Thyronines as a New Chemotype of Transcriptional CDK Inhibitors: An HTS-Driven Drug Repurposing Study

Sandip Bibishan Bharate
article en

Abstract

No abstract available for this paper.
Zenodo (CERN European Organization for Nuclear Research)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Thyronines as a New Chemotype of Transcriptional CDK Inhibitors: An HTS-Driven Drug Repurposing Study — Sandip Bibishan Bharate · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS